Oncopharmpod
Jan 2024 Updates...
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:15:25
- More information
Informações:
Synopsis
...on FDA approvals for belzutifan for RCC, pembrolizumab + cisplatin/RT for cervical cancer, erdafitinib (FGFR3 alterations only) for bladder cancer. Plus, early morning ICIs (https://doi.org/10.1016/j.ejca.2024.113571) & FLAG-Ida-GO in AML from NCRI AML 19 (https://doi.org/10.1200/JCO.23.00943)
